Lung cancer patient becomes tumor-free after treatment with selenite
A case report from Karolinska University Hospital details a patient with advanced, treatment-resistant lung cancer who became tumor-free after receiving selenite. While the results are promising, researchers emphasize that larger studies are needed to confirm the efficacy of selenium compounds as a cancer treatment.
Why it matters
This highlights a potential low-cost, low-side-effect therapeutic avenue for advanced cancer patients.
edited by Sadie Harley , reviewed by Robert Egan
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Add as preferred source CT and PET-CT findings during the clinical course. Credit: Oncology and Therapy (2026). DOI: 10.1007/s40487-026-00460-9 A patient with advanced, treatment-resistant lung cancer became tumor-free after treatment with the selenium compound selenite. This is shown in a new study from Karolinska University Hospital and Karolinska Institutet published in the journal Oncology and Therapy as a case report . The findings may contribute to increased knowledge about selenite as a possible cancer treatment.
In the published case report, a patient with advanced progressive lung cancer took part in a study in which selenite was given to patients with treatment-resistant cancer.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in